Malaria Burden and Artemisinin Resistance in the Mobile and Migrant Population on the Thai–Myanmar Border, 1999–2011: An Observational Study
Open accessThe DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Shoklo Malaria Research Unit has been working on the Thai-Myanmar border for 25 y providing early diagnosis and treatment (EDT) of malaria. Transmission of Plasmodium falciparum has declined, but resistance to artesunate has emerged. We expanded malaria activities through EDT and evaluated the impact over a 12-y period. METHODS AND FINDINGS: Between 1 October 1999 and 30 September 2011, the Shoklo Malaria Research Unit increased the number of cross-border (Myanmar side) health facilities from two to 11 and recorded the number of malaria consultations. Changes in malaria incidence were estimated from a cohort of pregnant women, and prevalence from cross-sectional surveys. In vivo and in vitro antimalarial drug efficacy were monitored. Over this period, the number of malaria cases detected increased initially, but then declined rapidly. In children under 5 y, the percentage of consultations due to malaria declined from 78% (95% CI 76-80) (1,048/1,344 consultations) to 7% (95% CI 6.2-7.1) (767/11,542 consultations), p<0.001. The ratio of P. falciparum/P. vivax declined from 1.4 (95% CI 1.3-1.4) to 0.7 (95% CI 0.7-0.8). The case fatality rate was low (39/75,126; 0.05% [95% CI 0.04-0.07]). The incidence of malaria declined from 1.1 to 0.1 episodes per pregnant women-year. The cumulative proportion of P. falciparum decreased significantly from 24.3% (95% CI 21.0-28.0) (143/588 pregnant women) to 3.4% (95% CI 2.8-4.3) (76/2,207 pregnant women), p<0.001. The in vivo efficacy of mefloquine-artesunate declined steadily, with a sharp drop in 2011 (day-42 PCR-adjusted cure rate 42% [95% CI 20-62]). The proportion of patients still slide positive for malaria at day 3 rose from 0% in 2000 to reach 28% (95% CI 13-45) (8/29 patients) in 2011. CONCLUSIONS: Despite the emergence of resistance to artesunate in P. falciparum, the strategy of EDT with artemisinin-based combination treatments has been associated with a reduction in malaria in the migrant population living on the Thai-Myanmar border. Although limited by its observational nature, this study provides useful data on malaria burden in a strategically crucial geographical area. Alternative fixed combination treatments are needed urgently to replace the failing first-line regimen of mefloquine and artesunate. Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The early detection and prompt treatment approach with combination therapy artesunate/mefloquine for P. falciparum and chloroquine for non-falciparum (principally P. vivax) infections, introduced in 1995, has been very effective and consistent with previous publications on malaria control in the Thailand-Myanmar border camps and for migrant populations (Landier et al., 2016; Carrara et al., 2013;”
From Mother, child and adolescent health outcomes in two long-term refugee camp settings at the Thai-Myanmar border 2000–2018: a retrospective analysis (2024) · cites this paper as Carrara et al., 2013
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The dramatic decline in malaria burden observed in the camps paralleled with the decreasing malaria incidence in the migrant population on the Thai–Myanmar border (Carrara et al., 2013), as did the increasing contribution of P. vivax to overall malaria morbidity”
From Integrated primary health care services in two protracted refugee camp settings at the Thai–Myanmar border 2000–2018: trends on mortality and incidence of infectious diseases (2022) · cites this paper as Carrara et al., 2013
In the citing paper
“As far as the authors are aware, this is the largest cohort demonstrating a significant association with low BMI and malaria among pregnant women (56) and, therefore, the history of malaria control efforts along the border over the present study period bears mentioning.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424 · cited 2×
“falciparum isolates that exhibit resistance to artesunate [3].”
BackgroundSelf-citationArtesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67176-0 · Cited by 1,050
Dondorp, A. M., Fanello, C. I., Hendriksen, I. C., Gomes, E., Seni, A., Chhaganlal, K. D., Bojang, K., Olaosebikan, R., Anunobi, N., Maitland, K., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61924-1 · Cited by 1,022
Self-citationThe global distribution and population at risk of malaria: past, present, and future
Hay, S. I., Guerra, C. A., Tatem, A. J., Noor, A. M., & Snow, R. W. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01043-6 · Cited by 1,001 · cited 1×
“In other continents, malaria has receded too, particularly in Southeast Asia, although the precise number of cases in some countries of the subcontinent may have been grossly underestimated [2].”
BackgroundEmergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
Phyo, A. P., Nkhoma, S., Stepniewska, K., Ashley, E. A., Nair, S., McGready, R., ler Moo, C., Al-Saai, S., Dondorp, A. M., Lwin, K. M., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60484-x · Cited by 924 · cited 2×
“falciparum resistance to artesunate [4].”
BackgroundSelf-citationDeterminants of relapse periodicity in Plasmodium vivax malaria
White, N. J. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-297 · Cited by 679
Self-citationNosten, F., van Vugt, M., Price, R., Luxemburger, C., Thway, K., Brockman, A., McGready, R., ter Kuile, F., Looareesuwan, S., & White, N. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02505-8 · Cited by 500 · cited 1×
“Between 1994 and 1999 we observed the impact of early detection and treatment (EDT) with ACT in populations of refugees living on the Thai–Myanmar border [9].”
BackgroundSelf-citationA Major Genome Region Underlying Artemisinin Resistance in Malaria
Cheeseman, I. H., Miller, B. A., Nair, S., Nkhoma, S., Tan, A., Tan, J. C., Al Saai, S., Phyo, A. P., Moo, C. L., Lwin, K. M., et al. (2012) · Science · doi:10.1126/science.1215966 · Cited by 381
Self-citationBarnes, K. I., Durrheim, D. N., Little, F., Jackson, A., Mehta, U., Allen, E., Dlamini, S. S., Tsoka, J., Bredenkamp, B., Mthembu, D. J., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020330 · Cited by 285 · cited 4×
“This approach used by SMRU as well as other health providers in the area had proven effectiveness first in the refugee camps on the Thai border in the 1990s , then in Thai villages of Tak province and elsewhere in the region [ 14 ] , and even in low transmission areas of Africa [ 15 ] .”
MethodInfluentialSelf-citationDelaying antimalarial drug resistance with combination chemotherapy.
White, N. J. (1999) · Parassitologia · Cited by 260
Self-citationTeuscher, F., Gatton, M. L., Chen, N., Peters, J., Kyle, D. E., & Cheng, Q. (2010) · The Journal of Infectious Diseases · doi:10.1086/656476 · Cited by 255
Korenromp, E. L., Williams, B. G., Gouws, E., Dye, C., & Snow, R. W. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00657-1 · Cited by 245 · cited 1×
“During the previous decades, the spread of chloroquine- and sulphadoxinepyrimethamine-resistant parasites from Southeast Asia to Africa resulted in a dramatic rise in mortality from increased perennial or epidemic transmission [5,6].”
BackgroundArtemisinin combination therapy for vivax malaria
Douglas, N. M., Anstey, N. M., Angus, B. J., Nosten, F., & Price, R. N. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70079-7 · Cited by 220
Self-citationMarsh, K. (1998) · The Lancet · doi:10.1016/s0140-6736(05)61510-3 · Cited by 208 · cited 1×
“During the previous decades, the spread of chloroquine- and sulphadoxinepyrimethamine-resistant parasites from Southeast Asia to Africa resulted in a dramatic rise in mortality from increased perennial or epidemic transmission [5,6].”
BackgroundMok, S., Imwong, M., Mackinnon, M. J., Sim, J., Ramadoss, R., Yi, P., Mayxay, M., Chotivanich, K., Liong, K.-Y., Russell, B., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-391 · Cited by 169 · cited 1×
“falciparum are exposed to artesunate (or its metabolite, dihydroartemisinin), a small proportion becomes metabolically inactive and insensitive to drugs, and these are not removed by the spleen, unlike those affected by the drug [22] and unlike what is normally seen in patients [23,24].”
BackgroundSelf-citationINTRACRANIAL HYPERTENSION AND STEROIDS.
Mattingly, D., Pm, D., Pearson, J., et al. (1964) · PubMed · Cited by 167
Intracranial Hypertension and Steroids
MATTINGLY, D., DENNIS, P. M., PEARSON, J., & COPE, C. L. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90998-5 · Cited by 166
Bed nets for the prevention of malaria and anaemia in pregnancy
Dolan, G., ter Kuile, F. O., Jacoutot, V., White, N. J., Luxemburger, C., Malankirii, L., Chongsuphajaisiddhi, T., & Nosten, F. (1993) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(93)90262-o · Cited by 157 · cited 1×
“maculatus) are forest mosquitoes feeding early in the evening and outdoors, such that the impact of impregnated nets is limited [17].”
BackgroundSelf-citationIntrahost modeling of artemisinin resistance in Plasmodium falciparum
Saralamba, S., Pan-Ngum, W., Maude, R. J., Lee, S. J., Tarning, J., Lindegårdh, N., Chotivanich, K., Nosten, F., Day, N. P. J., Socheat, D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006113108 · Cited by 156 · cited 1×
“falciparum are exposed to artesunate (or its metabolite, dihydroartemisinin), a small proportion becomes metabolically inactive and insensitive to drugs, and these are not removed by the spleen, unlike those affected by the drug [22] and unlike what is normally seen in patients [23,24].”
BackgroundSelf-citationCarrara, V. I., Sirilak, S., Thonglairuam, J., Rojanawatsirivet, C., Proux, S., Gilbos, V., Brockman, A., Ashley, E. A., McGready, R., Krudsood, S., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030183 · Cited by 146 · cited 2×
“Indeed, we have shown that the proportion of patients with multiple copies of the gene Pfmdr1 (known to mediate resistance to mefloquine) is increasing, which may have contributed to the decline in the in vivo efficacy of the MAS3 combination recently reported, although the number of participants recruited in 2011 was…”
BackgroundResultSelf-citationBrockman, A., Paul, R. E., Anderson, T. J., Hackford, I., Phaiphun, L., Looareesuwan, S., Nosten, F., & Day, K. P. (1999) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.1999.60.14 · Cited by 146 · cited 3×
“The day - 42 PCR - corrected cure rates and the proportion of patients still parasitaemic at day 3 are shown in Figure 7 .”
MethodInfluentialSelf-citationHIGH RATE OF PLASMODIUM VIVAX RELAPSE FOLLOWING TREATMENT OF FALCIPARUM MALARIA IN THAILAND
Looareesuwan, S., White, N. J., BUNNAG, D., Chittamas, S., & Harinasuta, T. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91479-6 · Cited by 144
Self-citationMalaria trends and challenges in the Greater Mekong Subregion.
Delacollette, C., D'Souza, C., Christophel, E. M., Thimasarn, K., Abdur, R., Bell, D., Dai, T. C., Gopinath, D., Lu, S., Mendoza, R., et al. (2009) · PubMed · Cited by 123
Artemisinin resistance in Plasmodium falciparum: A process linked to dormancy?
Cheng, Q., Kyle, D. E., & Gatton, M. L. (2012) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2012.01.001 · Cited by 93 · cited 1×
“Whether the two observations (dormancy and the slow clearance phenotype) are related is unknown but cannot be excluded [25,26].”
BackgroundVerdrager, J. (1986) · PubMed · Cited by 83
Phyo, A. P., Lwin, K. M., Price, R. N., Ashley, E. A., Russell, B., Sriprawat, K., Lindegardh, N., Singhasivanon, P., White, N. J., & Nosten, F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir631 · Cited by 72 · cited 1×
“vivax is becoming more resistant to chloroquine in this area [27], and this finding may explain the increasing proportion of patients presenting with vivax gametocytes (Figure 2).”
BackgroundSelf-citationNosten, F. H. (2010) · The Journal of Infectious Diseases · doi:10.1086/656478 · Cited by 26 · cited 1×
“Whether the two observations (dormancy and the slow clearance phenotype) are related is unknown but cannot be excluded [25,26].”
BackgroundSelf-citationDecludt, B., Pécoul, B., Biberson, P., Lang, R., & Imivithaya, S. (1991) · PubMed · Cited by 10
Cited by
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314981 · Cited by 2,205
Self-citationAntimalarial Drug Resistance: A Threat to Malaria Elimination
Menard, D., & Dondorp, A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025619 · Cited by 499
“2016) and with artesunate–mefloquine on the Thai–Myanmar border (Carrara et al. 2013).”
BackgroundInfluentialWorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group (2015) · BMC Medicine · doi:10.1186/s12916-015-0456-7 · Cited by 464
Tun, K. M., Imwong, M., Lwin, K. M., Win, A. A., Hlaing, T. M., Hlaing, T., Lin, K., Kyaw, M. P., Plewes, K., Faiz, M. A., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70032-0 · Cited by 414
Self-citationArtemisinin Action and Resistance in Plasmodium falciparum
Tilley, L., Straimer, J., Gnädig, N. F., Ralph, S. A., & Fidock, D. A. (2016) · Trends in Parasitology · doi:10.1016/j.pt.2016.05.010 · Cited by 359
“Thus it is of acute concern that resistance to the artemisinin derivatives (ARTs, see Glossary), the first-line drug class used to treat malaria, emerged several years ago, and is now evident in six countries in South East Asia.”
Metadata
- Authors
- Carrara, V. I., Lwin, K. M., Phyo, A. P., Ashley, E., Wiladphaingern, J., Sriprawat, K., Rijken, M., Boel, M., McGready, R., Proux, S., Chu, C., Singhasivanon, P., White, N., & Nosten, F.
- Affiliations
- University of Oxford (GB)
- Shoklo Malaria Research Unit (TH)
- University Medical Center Utrecht (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Mahidol University (TH)
- Corresponding author
- Nosten, François
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-03-05
- Volume
- 10
- Issue
- 3
- Pages
- e1001398
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC3589269
- OpenAlex
- W2027634352
- Cited by
- 185
- References
- 29
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 8 · 2023: 13 · 2022: 6 · 2021: 5 · 2020: 7 · 2019: 18 · 2018: 10 · 2017: 24 · 2016: 27 · 2015: 28 · 2014: 18 · 2013: 8
- FWCI
- 27.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Greater South Information System
- Funders
- Wellcome Trust (089275)
- Mahidol University
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Phytochemical compounds biological activities
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Travel-related health issues
- Keywords
- malaria, Plasmodium falciparum, artemisinin resistance, artesunate, antimalarial drug efficacy, malaria incidence, malaria prevalence, pregnant women, children under five, Plasmodium vivax, case fatality rate, cross-border healthcare, Thai-Myanmar border, Shoklo Malaria Research Unit
- MeSH terms
- Artesunate, Antimalarials, Myanmar, Climate, Community Health Workers, Cross-Sectional Studies, Drug Resistance, Female, Geography, Hospitalization, Humans, Malaria, Plasmodium falciparum, Plasmodium vivax, Pregnancy, Rain, Temperature, Thailand, Transients and Migrants, Reproducibility of Results, Pregnancy Complications, Parasitic, Mefloquine, Prevalence, Artemisinins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.